Clinical Trials Browser

Phase 2 × Glioblastoma × cabozantinib × Clear all

NCT01068782 2026-02-25

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Phase 2 Terminated

19 enrolled 10 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT02885324 2022-10-06

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Phase 2 Terminated

4 enrolled 6 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma